Scandinavian Journal of Rheumatology

Magnetic resonance imaging in the assessment of metacarpophalangeal joint disease in early psoriatic and rheumatoid arthritis
pp. 79-83(5)
Authors: Marzo-Ortega, H.; Tanner, S. F.; Rhodes, L. A.; Tan, A. L.; Conaghan, P. G.; Hensor, E. M. A.; Radjenovic, A.; O'Connor, P.; Emery, P.; McGonagle, D.

Prevalence of spondyloarthritis in 504 Chinese patients with HLA-B27-associated acute anterior uveitis
pp. 84-90(7)
Authors: Chung, Y-M.; Liao, H-T.; Lin, K-C.; Lin, Y-C.; Chou, C-T.; Chen, C-H.; Tsai, C-P.

Lack of association between beta 2-adrenergic receptor polymorphisms and juvenile idiopathic arthritis
pp. 91-95(5)
Authors: Pont-Kingdon, G.; Bohnsack, J.; Sumner, K.; Whiting, A.; Clifford, B.; Guthery, S. S.; Jorde, L. B.; Lyon, E.; Prahalad, S.

Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis
pp. 96-103(8)
Authors: Puolakka, K.; Kautiainen, H.; Mottonen, T.; Hannonen, P.; Korpela, M.; Hakala, M.; Luukkainen, R.; Vuori, K.; Blåfield, H.; Leirisalo-Repo, M.

Rhein, the metabolite of diacerhein, reduces the proliferation of osteoarthritic chondrocytes and synoviocytes without inducing apoptosis
pp. 104-111(8)
Authors: Legendre, F.; Heuze, A.; Boukerrouche, K.; Leclercq, S.; Boumediene, K.; Galera, P.; Domagala, F.; Pujol, J. -P.; Ficheux, H.

Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha
pp. 112-120(9)
Authors: Habib, H. M.; Taher, T. E.; Isenberg, D. A.; Mageed, R. A.

Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study
pp. 121-127(7)
Authors: Mok, C. C.; Ho, L. Y.; Cheung, M. Y.; Yu, K. L.; To, C. H.

Occurrence of systemic lupus erythematosus in a Danish community: an 8-year prospective study
pp. 128-132(5)
Authors: Laustrup, H.; Voss, A.; Green, A.; Junker, P.

A randomized, multicentre, double-blind, parallel-group study to assess the adverse event-related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis
pp. 133-143(11)
Authors: Dahlberg, L. E.; Holme, I.; Høye, K.; Ringertz, B.

Expression of the class I interferon-related MxA protein in temporal arteries in polymyalgia rheumatica and temporal arteritis
pp. 144-148(5)
Authors: Nordborg, C.; Larsson, K.; Åman, P.; Nordborg, E.

The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency
pp. 149-153(5)
Authors: Leventis, P.; Kiely, P. D. W.

Immunohistological features of hip synovitis in ankylosing spondylitis with advanced hip involvement
pp. 154-155(2)
Authors: Chen, W. S.; Chen, C. H.; Lin, K. C.; Tsai, C. Y.; Liao, H. T.; Wang, H. B.; Chen, Y. K.; Yang, A. H.; Chen, T. C.; Chou, C. T.

Familial presentation of bamboo spine, peripheral calcifications, and normal sacroiliac joints
pp. 156-157(2)
Authors: Branten, A. J. W.; de Jong, A. J. L.; Janssen, M.

Anti-inflammatory and anti-atherogenic effects of adiponectin in patients with rheumatoid arthritis following anti-TNF therapy
pp. 158-158(1)
Author: Kapoor, S.